Ganga Pharmaceuticals has informed that Annual Secretarial Compliance Report under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018 read with BSE Circular LIST/COMP/10/2019-20 dated May 09, 2019 is not applicable to company. Further, as per the provisions of Regulation 15 of SEBI (Listing obligations and Disclosure Requirements) Regulation, 2015 the compliance with the corporate governance provisions as specified in regulation 24A shall not apply, in respect of: The listed entity having paid up equity share capital not exceeding rupees ten crore and net worth not exceeding rupees twenty five crore, as on the last day of the previous financial year; The listed entity which has listed its specified securities on the SME Exchange.
The above information is a part of company’s filings submitted to BSE.